STRANGEWORKS, INC. – Trademark Portfolio
Entity Type: 03
STRANGEWORKS, INC. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 13 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 6 trademarks are registered and 2 are pending. Notable registered marks include STRANGEWORKS, HUMANIZING QUANTUM, HERDING SCHRÖDINGER'S CATS, and THE IMPOSSIBILITIES ARE ENDLESS. The owner is based in AUSTIN, TX.
2922 E. CESAR CHAVEZ ST.
AUSTIN, TX 78702
Showing of trademarks Trademarks
Trademark Classifications
STRANGEWORKS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does STRANGEWORKS, INC. have?
STRANGEWORKS, INC. has 14 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 pending, 6 abandoned.
What trademark classes does STRANGEWORKS, INC. file in?
STRANGEWORKS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are STRANGEWORKS, INC.'s most well-known trademarks?
STRANGEWORKS, INC.'s registered trademark portfolio includes well-known marks such as STRANGEWORKS, HUMANIZING QUANTUM, HERDING SCHRÖDINGER'S CATS, and THE IMPOSSIBILITIES ARE ENDLESS. These are among 6 currently registered trademarks in the portfolio.
What is STRANGEWORKS, INC.'s trademark registration success rate?
STRANGEWORKS, INC. has a 50% trademark registration rate, with 6 out of 12 resolved applications resulting in successful registration. Currently, 2 applications are pending review.